Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 6Gastritis 5Lymphoma, B-Cell, Marginal Zone 4Dyspepsia 4Peptic Ulcer 3Lymphoma 3Neoplasms 2Stomach Ulcer 1Skin Neoplasms 1Pseudomyxoma Peritonei 1Neutropenia 1Neoplasms, Plasma Cell 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Leukemia 1Infections 1Hematologic Neoplasms 1Helicobacter Infections 1Head and Neck Neoplasms 1Glioblastoma 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Fever 1Familial primary gastric lymphoma 1Cystectomy 1Chemotherapy Effect 1Brain Neoplasms 1Astrocytoma 1Appendiceal Neoplasms 1Agammaglobulinemia 1

Interventions

Mitomycin 3Hyperthermic Intraperitoneal Chemotherapy 3Surveys and Questionnaires 2Fluorouracil 2Capecitabine 2tislelizumab 1molgramostim 1irinotecan sucrosofate 1Tacrolimus 1Standard of Care 1Sirolimus 1Referral and Consultation 1Radiosurgery 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Oxaliplatin 1Observation 1Methods 1Leucovorin 1Lansoprazole 1Ifosfamide 1Gemcitabine 1Early Intervention, Educational 1Doxorubicin 1Cytoreduction Surgical Procedures 1Clarithromycin 1Cisplatin 1Carboplatin 1Bromelains 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pseudomyxoma Peritonei × Amoxicillin × Clear all
NCT02387203 2024-11-19

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Mercy Medical Center

Phase 2 Active not recruiting
80 enrolled
Gastrointestinal

Appendiceal Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡